News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
37–72
Matches
3731
Sources here
19
Companies here
23
Search results Stored financial headlines

Active search

3731 matching headlines

Ticker or company: MEDIMain company stories
Clear

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

Kestra Medical Technologies CEO Brian Webster sells $692,214 in stock

Kestra Medical Technologies CEO Brian Webster recently sold $692,214 worth of company stock across three transactions between July 30 and August 3, 2026. These sales were nondiscretionary, executed to cover tax withholding obligations related to restricted stock unit vesting. The company has seen significant …

KMTS main company
Sharemaestro market context Trend signal started 52 weeks +50.8% KMTS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Kestra Medical CBO Timothy Moran sells $348,310 in shares

Kestra Medical's CBO, Timothy P. Moran, sold $348,310 worth of common shares in late July and early August 2026 to cover tax withholding obligations. Following these transactions, Moran directly owns 66,345 shares. The stock has appreciated significantly since then, despite the company missing Wall …

KMTS main company
Sharemaestro market context Trend signal started 52 weeks +50.8% KMTS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Kestra Medical Technologies officer Traci Umberger sells $512,791

Traci S. Umberger, General Counsel and Chief Administrative Officer at Kestra Medical Technologies, sold common shares worth $512,791 between July 30 and August 3, 2026. These non-discretionary sales were conducted to cover tax withholding obligations related to restricted stock unit vesting. Following these transactions, …

KMTS main company
Sharemaestro market context Trend signal started 52 weeks +50.8% KMTS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

CCORF Maintains Orthofix Medical(OFIX.US) With Buy Rating, Maintains Target Price $13

CCORF has reiterated its Buy rating for Orthofix Medical (OFIX.US), maintaining a target price of $13. This indicates a continued positive outlook on the company's stock performance by the firm.

OFIX main company
Sharemaestro market context Price below Trend Line 52 weeks -28.9% OFIX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Q1 2026 ICU Medical Inc Earnings Call Transcript

This article provides the edited transcript of ICU Medical Inc.'s Q1 2026 earnings call, which took place on May 7, 2026. The call began with an introduction from an unidentifiable speaker, followed by Thompson from ICR who welcomed participants to discuss the financial results. …

ICUI main company
Sharemaestro market context Trend signal active 52 weeks +42.8% ICUI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Merit Medical Systems Eyes New Long-Range Plan as Growth, Margins Gain Momentum

Merit Medical Systems (MMSI) is developing a new long-range plan, building on recent revenue and margin growth under new CEO Martha. The company has reorganized its reporting structure into Foundational and Therapeutic product categories and is focusing on disciplined M&A to deepen existing market …

MMSI main company
Sharemaestro market context Price above Trend Line 52 weeks +1.5% MMSI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Merit Medical Systems, Inc. $MMSI Shares Purchased by Quantinno Capital Management LP

Quantinno Capital Management LP significantly increased its stake in Merit Medical Systems (MMSI) by 200.3% in the first quarter, now owning 17,612 shares valued at approximately $1.21 million. This comes as institutional investors collectively hold 99.66% of the stock, and analysts maintain a "Moderate …

MMSI main company
Sharemaestro market context Price above Trend Line 52 weeks +1.5% MMSI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Wall Street Zen Upgrades Vivani Medical (NASDAQ:VANI) to "Hold"

Wall Street Zen has upgraded Vivani Medical (NASDAQ:VANI) from a "sell" to a "hold" rating, contributing to a consensus "Hold" rating with an average price target of $3.75. Analyst opinions are varied, with Lake Street Capital initiating coverage with a "buy" rating and a …

VANI main company
Sharemaestro market context Trend signal active 52 weeks +12.9% · Next-week setup negative 42.2% VANI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Wall Street Zen Downgrades MediWound (NASDAQ:MDWD) to Strong Sell

Wall Street Zen has downgraded MediWound (NASDAQ:MDWD) from "sell" to "strong sell," despite the broader analyst consensus being "Hold" with an average price target of $33.00. MediWound's shares opened at $13.56, close to its 12-month low, and the company recently missed quarterly earnings expectations …

MDWD main company
Sharemaestro market context Price below Trend Line 52 weeks -23.0% MDWD stored weekly price path from 22 Aug 2025 to 14 Aug 2026

MediWound (MDWD) Stock Faces Cash Burn As Revenue Slips

MediWound (MDWD) reported a Q2 revenue of US$3.1 million and a net loss of US$7.4 million, reflecting a revenue decline but a narrowed loss per share year-over-year. The company's cash burn and reliance on two key assets, EscharEx and NexoBrid, are concerns, despite reaffirming …

MDWD main company
Sharemaestro market context Price below Trend Line 52 weeks -23.0% MDWD stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Parabilis Medicines(PBLS) Stock Options Chain | Quotes & News

The article provides information related to Parabilis Medicines (PBLS) stock options chain, including quotes and news. The content itself is not available in the provided input.

PBLS main company
Sharemaestro market context Stored weekly price path 10 weeks +36.0% · Next-week setup positive 76.4% PBLS stored weekly price path from 12 Jun 2026 to 14 Aug 2026

Prime Medicine, Inc. Stock 12‑Month Price Target Cut to $6.92, Implies 124% Upside

The average 12-month price target for Prime Medicine, Inc. (PRME) stock has been lowered from $7.12 to $6.92 by 9 analysts, yet this new target still suggests a significant 124% potential upside from its August 14th closing price. The consensus rating for PRME remains …

PRME main company
Sharemaestro market context Price below Trend Line 52 weeks -13.0% PRME stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Vivani Medical (NASDAQ: VANI) Completes Full Enrollment In Semaglutide Implant Trial, Strikes Novo Nordisk Deal

Vivani Medical (NASDAQ: VANI) announced full enrollment in its SLIM-1 Phase 1 trial for NPM-139, a semaglutide implant, with top-line data expected in November 2026. The company also signed a non-exclusive agreement with Novo Nordisk for evaluating NPM-139 and its NanoPortal technology. Additionally, Vivani …

VANI main company
Sharemaestro market context Trend signal active 52 weeks +12.9% · Next-week setup negative 42.2% VANI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Insider Selling: Disc Medicine (NASDAQ:IRON) COO Sells 804 Shares

Disc Medicine (NASDAQ:IRON) COO Jonathan Yen-Wen Yu recently sold 804 shares of the company's stock for $66,442.56, reducing his total holdings by 1.46%. This sale is part of a series of insider transactions since mid-June. Despite these sales, the company exceeded its recent quarterly …

IRON main company
Sharemaestro market context Trend signal active 52 weeks +30.6% IRON stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Disc Medicine COO Jonathan Yu sells $66,444 in shares By Investing.com

Disc Medicine's COO, Jonathan Yu, sold 804 shares of the company's common stock for a total of $66,444 at an average price of $82.6425. This transaction was part of a pre-arranged trading plan, and it occurred as the stock had seen a 41% return …

IRON main company
Sharemaestro market context Trend signal active 52 weeks +30.6% IRON stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Disc Medicine (NASDAQ: IRON) COO trades 804 shares via 10b5-1 plan

Disc Medicine's COO, Yu Jonathan Yen-Wen, exercised stock options for 804 shares at $13.50 each and simultaneously sold these 804 shares at a weighted average price of $82.6425. These transactions, which generated an approximate pre-tax spread of $56,000, were conducted under a pre-arranged Rule …

IRON main company
Sharemaestro market context Trend signal active 52 weeks +30.6% IRON stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Is BeOne Medicines AG (ONC) Deal With Revolution Medicines (RVMD) a Win-Win for Both Companies?

Two oncology powerhouses, BeOne Medicines AG (NASDAQ:ONC) and Revolution Medicines, Inc. (NASDAQ:RVMD), announced a major multi-part clinical collaboration and regional licensing deal. Under the August 10 agreement, the companies will combine select clinical-stage assets from BeOne with Revolution's four clinical-stage RAS(ON) inhibitors to evaluate …

6160 main company B1ME34 main company RVMD main company
Sharemaestro market context Price above Trend Line 52 weeks +12.7% 6160 stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Trump Media's Stock Fell 54%. Here's What Its Technology Chief's Latest Filing Signals

Vladimir Novachki, the chief technology officer of Trump Media & Technology Group Corp. (NASDAQ:DJT), disposed of 29,957 shares of common stock on August 13, according to a recent SEC Form 4 filing. Transaction summary Metric Value Shares sold (direct) 29,957 Transaction value $249,542 Post-transaction …

DJT main company
Sharemaestro market context Price below Trend Line 52 weeks -53.7% DJT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Should You Worry About Trump Media Insider Activity as the Stock Falls? Here's How to Read It

Kevin McGurn, the company's interim CEO, reported the disposition of 16,509 shares of Trump Media & Technology Group Corp. (NASDAQ:DJT) on August 13, according to an SEC Form 4 filing. Transaction summary Metric Value Transaction value $137,520 Shares sold 16,509 Post-transaction shares (directly held) …

DJT main company
Sharemaestro market context Price below Trend Line 52 weeks -53.7% DJT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Perceptive Advisors (NVNO) reports 3.5% beneficial stake via 24,605 warrants

Perceptive Advisors LLC, Joseph Edelman, and Perceptive Life Sciences Master Fund, Ltd. have reported a beneficial ownership of 3.5% in enVVeno Medical Corporation (NVNO) through 24,605 exercisable warrants. This stake represents 24,605 shares of common stock, based on 682,722 shares outstanding as of July …

NVNO main company
Sharemaestro market context Price above Trend Line 52 weeks -68.6% NVNO stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Modular Medical, Inc. Q1 FY2027: Net loss $(6.49M), EPS $(1.19) — 10-Q Summary

Modular Medical, Inc. (MODD) reported a net loss of $(6.49M) for Q1 FY2027, an improvement from the prior year, with diluted loss per share at $(1.19). The company's cash and cash equivalents significantly decreased, leading to a flagged going-concern risk due to liquidity issues. …

MODD main company
Sharemaestro market context Price below Trend Line 52 weeks -88.5% · Next-week setup negative 42.7% MODD stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context